Correction: Protein tyrosine phosphataselike A regulates myoblast proliferation and differentiation through MyoG and the cell cycling signaling pathway [Molecular and Cellular Biology,(2012), (297-308),32, 2] https://doi.org/10.1128/MCB.05484-11;Protein tyrosine phosphatase-like a regulates myoblast proliferation and differentiation through myog and the cell cycling signaling pathway

Molecular and Cellular Biology

Volumn 32, Issue 2, 2012, Pages 297-308

  Lin, Xi ^a   Yang, Xiangsheng ^a   Li, Qi ^b   Ma, Yanlin ^b   Cui, Shuang ^c   He, Dacheng ^c   Lin, Xia ^d   Schwartz, Robert J ^e   Changa, Jiang ^a,b  

^a TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

^b HAINAN MEDICAL UNIVERSITY   (China)

^c BEIJING NORMAL UNIVERSITY   (China)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

^e UNIVERSITY OF HOUSTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; CYCLIN DEPENDENT KINASE 1; CYCLIN E; MESSENGER RNA; MYOGENIN; PHOSPHATASE; PROTEIN P21; PROTEIN TYROSINE PHOSPHATASE LIKE A; SERUM RESPONSE FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BINDING SITE; CELL CYCLE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE PROGRESSION; CELL DIFFERENTIATION; CELL MATURATION; CELL PROLIFERATION; CONTROLLED STUDY; DNA SYNTHESIS; ENZYME ACTIVATION; ENZYME ACTIVITY; GENE INACTIVATION; HEART MUSCLE; IN VITRO STUDY; INTRACELLULAR SIGNALING; MOUSE; MUSCLE DEVELOPMENT; MYOBLAST; MYOTUBE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; S PHASE CELL CYCLE CHECKPOINT; SKELETAL MUSCLE; TRANSCRIPTION REGULATION;

CANIS FAMILIARIS; MUS;

EID: 84863011377     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.00236-17     Document Type: Erratum

References (66)

1. Adham IM, et al. 2005. The scoliosis (sco) mouse: a new allele of Pax1. Cytogenet. Genome Res. 111:16-26.
2. Agnati LF, et al. 2006. Allosteric modulation of dopamine D2 receptors by homocysteine. J. Proteome Res. 5:3077-3083.
3. Arnold SR, et al. 2006. Changing patterns of acute hematogenous osteomyelitis and septic arthritis: emergence of community-associated methicillin-resistant Staphylococcus aureus. J. Pediatr. Orthop. 26: 703-708.
4. Arsenian S, Weinhold B, Oelgeschlager M, Ruther U, Nordheim A. 1998. Serum response factor is essential for mesoderm formation during mouse embryogenesis. EMBO J. 17:6289-6299.
5. Atherton-Fessler S, et al. 1994. Cell cycle regulation of the p34cdc2 inhibitory kinases. Mol. Biol. Cell 5:989-1001.
6. Barnoud R, et al. 2000. Immunohistochemical expression of WT1 by desmoplastic small round cell tumor: a comparative study with other small round cell tumors. Am. J. Surg. Pathol. 24:830-836.
7. Bartkova J, et al. 2005. DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis. Nature 434:864-870.
8. Beggs AH, et al. 2010. MTM1 mutation associated with X-linked myotubular myopathy in Labrador Retrievers. Proc. Natl. Acad. Sci. U. S. A. 107:14697-14702.
9. Berkes CA, Tapscott SJ. 2005. MyoD and the transcriptional control of myogenesis. Semin. Cell Dev. Biol. 16:585-595.
10. Braun T, Bober E, Winter B, Rosenthal N, Arnold HH. 1990. Myf-6, a new member of the human gene family of myogenic determination factors: evidence for a gene cluster on chromosome 12. EMBO J. 9:821- 831.
11. Braun T, Buschhausen-Denker G, Bober E, Tannich E, Arnold HH. 1989. A novel human muscle factor related to but distinct from MyoD1 induces myogenic conversion in 10T1/2 fibroblasts. EMBO J. 8:701-709.
12. Brüning JC, et al. 1998. A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance. Mol. Cell 2:559-569.
13. Chang J, Knowlton AA, Wasser JS. 2000. Expression of heat shock proteins in turtle and mammal hearts: relationship to anoxia tolerance. Am. J. Physiol. Regul. Integr. Comp. Physiol. 278:R209-R214.
14. Chang J, et al. 2003. Inhibitory cardiac transcription factor, SRF-N, is generated by caspase 3 cleavage in human heart failure and attenuated by ventricular unloading. Circulation 108:407- 413.
15. Chen CY, Schwartz RJ. 1996. Recruitment of the tinman homolog Nkx-2.5 by serum response factor activates cardiac alpha-actin gene transcription. Mol. Cell. Biol. 16:6372- 6384.
16. Coolican SA, Samuel DS, Ewton DZ, McWade FJ, Florini JR. 1997. The mitogenic and myogenic actions of insulin-like growth factors utilize distinct signaling pathways. J. Biol. Chem. 272:6653- 6662.
17. Davis RL, Weintraub H, Lassar AB. 1987. Expression of a single transfected cDNA converts fibroblasts to myoblasts. Cell 51:987-1000.
18. de Oliveira MV, et al. 2009. SHP-2 regulates myogenesis by coupling to FAK signaling pathway. FEBS Lett. 583:2975-2981.
19. Du SJ, Gao J, Anyangwe V. 2003. Muscle-specific expression of myogenin in zebrafish embryos is controlled by multiple regulatory elements in the promoter. Comp. Biochem. Physiol. B Biochem. Mol. Biol. 134: 123-134.
20. Edmondson DG, Olson EN. 1989. A gene with homology to the myc similarity region of MyoD1 is expressed during myogenesis and is sufficient to activate the muscle differentiation program. Genes Dev. 3:628-640.
21. Ewen ME. 2000. Where the cell cycle and histones meet. Genes Dev. 14:2265-2270.
22. Fornaro M, et al. 2006. SHP-2 activates signaling of the nuclear factor of activated T cells to promote skeletal muscle growth. J. Cell Biol. 175: 87-97.
23. Goel HL, Dey CS. 2002. Focal adhesion kinase tyrosine phosphorylation is associated with myogenesis and modulated by insulin. Cell Prolif. 35: 131-142.
24. Goel HL, Dey CS. 2002. PKC-regulated myogenesis is associated with increased tyrosine phosphorylation of FAK, Cas, and paxillin, formation of Cas-CRK complex, and JNK activation. Differentiation 70:257-271.
25. Hasty P, et al. 1993. Muscle deficiency and neonatal death in mice with a targeted mutation in the myogenin gene. Nature 364:501-506.
26. Healy C, Uwanogho D, Sharpe PT. 1999. Regulation and role of Sox9 in cartilage formation. Dev. Dyn. 215:69-78.
27. Hinard V, Belin D, Konig S, Bader CR, Bernheim L. 2008. Initiation of human myoblast differentiation via dephosphorylation of Kir2.1 K+ channels at tyrosine 242. Development 135:859-867.
28. Huang C, et al. 2010. Reduction of PKCbetaII activity in smooth muscle cells attenuates acute arterial injury. Atherosclerosis 212:123-130.
29. Johanson M, et al. 1999. Transcriptional activation of the myogenin gene by MEF2-mediated recruitment of myf5 is inhibited by adenovirus E1A protein. Biochem. Biophys. Res. Commun. 265:222-232.
30. Kaliman P, Vinals F, Testar X, Palacin M, Zorzano A. 1996. Phosphatidylinositol 3-kinase inhibitors block differentiation of skeletal muscle cells. J. Biol. Chem. 271:19146-19151.
31. Konishi H, Okuda A, Ohno Y, Kihara A. 2010. Characterization of HACD1 K64Q mutant found in arrhythmogenic right ventricular dysplasia patients. J. Biochem. 148:617- 622.
32. Kontaridis MI, et al. 2004. SHP-2 positively regulates myogenesis by coupling to the Rho GTPase signaling pathway. Mol. Cell. Biol. 24: 5340-5352.
33. Kontaridis MI, Liu X, Zhang L, Bennett AM. 2001. SHP-2 complex formation with the SHP-2 substrate-1 during C2C12 myogenesis. J. Cell Sci. 114:2187-2198.
34. Koyama T, et al. 2008. Interaction of scaffolding adaptor protein Gab1 with tyrosine phosphatase SHP2 negatively regulates IGF-I-dependent myogenic differentiation via the ERK1/2 signaling pathway. J. Biol. Chem. 283:24234-24244.
35. Laporte J, et al. 1997. Mutations in the MTM1 gene implicated in X-linked myotubular myopathy. ENMC International Consortium on Myotubular Myopathy. European Neuro-Muscular Center. Hum. Mol. Genet. 6:1505-1511.
36. Laporte J, et al. 1996. A gene mutated in X-linked myotubular myopathy defines a new putative tyrosine phosphatase family conserved in yeast. Nat. Genet. 13:175-182.
37. Lauper N, et al. 1998. Cyclin E2: a novel CDK2 partner in the late G1 and S phases of the mammalian cell cycle. Oncogene 17:2637-2643.
38. Li D, Gonzalez O, Bachinski LL, Roberts R. 2000. Human protein tyrosine phosphatase-like gene: expression profile, genomic structure, and mutation analysis in families with ARVD. Gene 256:237-243.
39. Li Q, Lin X, Yang X, Chang J. 2010. NFATc4 is negatively regulated inmiR-133a-mediated cardiomyocyte hypertrophic repression. Am. J. Physiol. Heart Circ. Physiol. 298:H1340-H1347.
40. Li S, et al. 2005. Requirement for serum response factor for skeletal muscle growth and maturation revealed by tissue-specific gene deletion in mice. Proc. Natl. Acad. Sci. U. S. A. 102:1082-1087.
41. Li S, Wang DZ, Wang Z, Richardson JA, Olson EN. 2003. The serum response factor coactivator myocardin is required for vascular smooth muscle development. Proc. Natl. Acad. Sci. U. S. A. 100:9366-9370.
42. Lu H, et al. 2002. The differentiation of skeletal muscle cells involves a protein-tyrosine phosphatase-alpha-mediated C-Src signaling pathway. J. Biol. Chem. 277:46687- 46695.
43. Lukas J, Bartkova J, Bartek J. 1996. Convergence of mitogenic signalling cascades from diverse classes of receptors at the cyclin D-cyclin-dependent kinase-pRb-controlled G1 checkpoint. Mol. Cell. Biol. 16:6917- 6925.
44. Lundberg AS, Weinberg RA. 1998. Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-cdk complexes. Mol. Cell. Biol. 18:753-761.
45. McGowan CH, Russell P. 1993. Human Wee1 kinase inhibits cell division by phosphorylating p34cdc2 exclusively on Tyr15. EMBO J. 12:75- 85.
46. Miano JM, et al. 2004. Restricted inactivation of serum response factor to the cardiovascular system. Proc. Natl. Acad. Sci. U. S. A. 101: 17132-17137.
47. Miner JH, Wold B. 1990. Herculin, a fourth member of the MyoD family of myogenic regulatory genes. Proc. Natl. Acad. Sci. U. S. A. 87: 1089-1093.
48. Nabeshima Y, et al. 1993. Myogenin gene disruption results in perinatal lethality because of severe muscle defect. Nature 364:532-535.
49. Niu Z, et al. 2005. Conditional mutagenesis of the murine serum response factor gene blocks cardiogenesis and the transcription of downstream gene targets. J. Biol. Chem. 280:32531-32538.
50. Norbury C, Blow J, Nurse P. 1991. Regulatory phosphorylation of the p34cdc2 protein kinase in vertebrates. EMBO J. 10:3321-3329.
51. Parlakian A, et al. 2004. Targeted inactivation of serum response factor in the developing heart results in myocardial defects and embryonic lethality. Mol. Cell. Biol. 24:5281-5289.
52. Pelé M, Tiret L, Kessler JL, Blot S, Panthier JJ. 2005. SINE exonic insertion in the PTPLA gene leads to multiple splicing defects and segregates with the autosomal recessive centronuclear myopathy in dogs. Hum. Mol. Genet. 14:1417-1427.
53. Quach NL, Biressi S, Reichardt LF, Keller C, Rando TA. 2009. Focal adhesion kinase signaling regulates the expression of caveolin 3 and beta1 integrin, genes essential for normal myoblast fusion. Mol. Biol. Cell 20: 3422-3435.
54. Quach NL, Rando TA. 2006. Focal adhesion kinase is essential for costamerogenesis in cultured skeletal muscle cells. Dev. Biol. 293:38-52.
55. Rhodes SJ, Konieczny SF. 1989. Identification of MRF4: a new member of the muscle regulatory factor gene family. Genes Dev. 3:2050-2061.
56. Ridgeway AG, Wilton S, Skerjanc IS. 2000. Myocyte enhancer factor 2C and myogenin up-regulate each other's expression and induce the development of skeletal muscle in P19 cells. J. Biol. Chem. 275:41- 46.
57. Sohal DS, et al. 2001. Temporally regulated and tissue-specific gene manipulations in the adult and embryonic heart using a tamoxifeninducible Cre protein. Circ. Res. 89:20-25.
58. Soulez M, et al. 1996. Growth and differentiation of C2 myogenic cells are dependent on serum response factor. Mol. Cell. Biol. 16:6065- 6074.
59. Sun L, Chang J, Kirchhoff SR, Knowlton AA. 2000. Activation of HSF and selective increase in heat-shock proteins by acute dexamethasone treatment. Am. J. Physiol. Heart Circ. Physiol. 278:H1091-H1097.
60. Suryawan A, Davis TA. 2003. Protein-tyrosine-phosphatase 1B activation is regulated developmentally in muscle of neonatal pigs. Am. J. Physiol. Endocrinol. Metab. 284:E47-E54.
61. Uwanogho DA, et al. 1999. Molecular cloning, chromosomal mapping, and developmental expression of a novel protein tyrosine phosphataselike gene. Genomics 62:406-416.
62. Wang B, Pelletier J, Massaad MJ, Herscovics A, Shore GC. 2004. The yeast split-ubiquitin membrane protein two-hybrid screen identifies BAP31 as a regulator of the turnover of endoplasmic reticulum-associated protein tyrosine phosphatase-like B. Mol. Cell. Biol. 24:2767-2778.
63. Wells NJ, et al. 1999. The C-terminal domain of the Cdc2 inhibitory kinase Myt1 interacts with Cdc2 complexes and is required for inhibition of G(2)/M progression. J. Cell Sci. 112(Pt. 19):3361-3371.
64. Wiebel FF, Rennekampff V, Vintersten K, Nordheim A. 2002. Generation of mice carrying conditional knockout alleles for the transcription factor SRF. Genesis 32:124-126.
65. Wright WE, Sassoon DA, Lin VK. 1989. Myogenin, a factor regulating myogenesis, has a domain homologous to MyoD. Cell 56:607- 617.
66. Zhang SX, et al. 2005. Identification of direct serum-response factor gene targets during Me2SO-induced P19 cardiac cell differentiation. J. Biol. Chem. 280:19115-19126.